Search Results 2101-2110 of 18867 for Relapse

1. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

   Each unique regimen or 'line' is defined as a single or combination of medications given for a new relapse/recurrence. Maintenance therapies, where ...

2. An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   ... relapse or who complete the Maintenance Study RPC01-3203, and subjects who complete a study of ozanimod for Crohn's Disease and meet the criteria for ...

3. Daclizumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

   This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used ...

4. Neurology - Clinical trials

   Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

5. A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments - Mayo Clinic

   ... relapsed/refractory multiple myeloma (RRMM). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

6. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   History of second malignancy, except those treated with curative intent more than five years previously without relapse or low likelihood of recurrence (for ...

7. Comprehensive testing leads to targeted treatment for rare autoimmune encephalitis antibody - Mayo Clinic News Network

   Spencer did have one slight relapse, which manifested as another persistent headache in January of 2022 and sent him back to an ER in the Twin Cities. An ...

8. MAYO MAGAZINE - Autumn 2008 - MC2386-AU08

   non-Hodgkin's lymphoma who relapse following chemotherapy. “BEXXAR is an intravenous monoclonal antibody that's directed against the proteins located in ...

9. Teriflunomide (oral route) - Side effects & dosage - Mayo Clinic

   This medicine will not cure MS, but it may slow some disabling effects and decrease the number of relapses of the disease. This medicine is available only ...

10. Clinical trials - Oncology (Medical)

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...